WHAT IS THE FUTURE OF VALUE-BASED CARE?

Commercial risk will be a critical catalyst of progress – it’s complicated, but is it possible? We think so.

X

Cheat Sheet

Ultra high-cost drugs

10 Minute Read

    Key Takeaways
    • Ultra high-cost drugs (UHCDs) are expensive, potentially durable, or curative therapies currently approved to treat conditions that are orphan and rare disease.
    • UHCDs are relatively new pharmaceutical products in the market, but their presence will almost certainly increase dramatically over the next decade.
    • UHCDs are disrupting three elements of healthcare: care delivery, generation of clinical evidence, and cost/payment models.

    Log in to access this content

    Log in

    Don't have an account? Learn about membership benefits

    Have a Question?

    x

    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.